We stand behind our service
Go directly to the lab, no extra fees
With friendly doctor's notes & guidance
Lab visit as quick as 10 mins in & out
We stand behind our service
Go directly to the lab, no extra fees
With friendly doctor's notes & guidance
Lab visit as quick as 10 mins in & out
This test is ideal if you've been diagnosed with melanoma, colorectal cancer, thyroid cancer, or other cancers and need to understand your treatment options. It identifies specific genetic mutations in the BRAF gene that can help your doctor determine which targeted therapies might work best for you. Many cancer patients use this test to clarify whether they're likely to respond to BRAF inhibitor medications or other targeted treatments.
Fasting is not required for this test. The test is performed on tumor tissue that has already been collected during a biopsy or surgery, so no additional blood draw or special preparation is needed. Your healthcare provider will submit your existing tumor sample to the laboratory for genetic analysis.
This test analyzes your tumor tissue for mutations in the BRAF gene, particularly the V600E mutation which is found in approximately 90% of BRAF mutations in cancer. The BRAF gene produces a protein involved in cell growth signaling, and mutations can cause cells to grow uncontrollably, leading to cancer. This genetic information helps determine whether you're a candidate for BRAF inhibitor therapy and can predict how your cancer might respond to certain treatments, making it essential for personalized cancer care.
What this means
Your test shows no BRAF V600E mutation was detected in your tumor sample. This means your cancer does not have this specific genetic change, which helps your oncologist understand which treatment options are most appropriate for you. While BRAF inhibitors may not be effective, other targeted therapies or treatment approaches can still be highly successful.
Recommended actions
Discuss alternative targeted therapy options with your oncologist based on your cancer type
Consider testing for other genetic mutations like RAS or other actionable markers
Work with your cancer care team to develop a personalized treatment plan
Maintain open communication with your healthcare providers about treatment response and any new symptoms